NCT06889012View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1018 and Coadministration of BR1018A and BR1018B in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 7, 2025

Primary Completion Date

July 23, 2025

Study Completion Date

July 23, 2025

Conditions
Essential HypertensionPrimary Hypercholesterolemia
Interventions
DRUG

BR1018

One tablet administered alone

DRUG

BR1018A

One tablet administered alone

DRUG

BR1018B

One tablet administered alone

Trial Locations (1)

Unknown

Clinical Research Center, H PLUS Yangji Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY

NCT06889012 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1018 and Coadministration of BR1018A and BR1018B in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter